Joseph Jimenez, the chief executive of Novartis, is celebrating a triumph. The Food and Drug Administration approved Kymriah, a new treatment for kids with leukemia. But he's also taking heat from all sides over his decision to charge $475,000 for the treatment, and, in a major first, to negotiate deals that charge only patients who go into remission.

Christopher Plascencia won a promotion last month to personal banker at Wells Fargo & Co.; now he's worried the career advancement might become a hollow gain.

For drone users, Hurricane Harvey is likely to be the event that propelled unmanned aircraft to become integral parts of government and corporate disaster-recovery efforts.

Sean Ramsden and his family have been shipping British food abroad since the U.K. joined the European Union more than four decades ago.

Futurists extol the virtues of the gig economy - a world of contract workers who call their own hours and enjoy a degree of independence not available to full-timers. But there's a downside to that scenario as well.